Refine
Has Fulltext
- yes (2)
Is part of the Bibliography
- yes (2)
Document Type
- Journal article (1)
- Doctoral Thesis (1)
Keywords
- Bhasa (1)
- Bhasa / Pratijna-Yaugandharayana (1)
- Drama (1)
- Sanskrit (1)
- drama (1)
- lung cancer (1)
- molecular alterations (1)
- prognostic awareness (1)
- quality of life (1)
- sanskrit (1)
Diese Dissertation enthält eine Edition und eine annotierte Übersetzung des dem Bhasa zugeschriebenen Sanskrit-Schauspiels "Pratijnayaugandharayana". Die Edition beruht auf zehn Manuskripten, von denen bisherige Ausgaben nur drei verwendet hatten. Um Zusammenhänge zwischen den Manuskripten sichtbar zu machen, und so deren jeweiligen Wert besser beurteilen zu können, werden quantitative Methoden verwendet. In diesem Zusammenhang wird die effektive Verwendung von EDV für die Veröffentlichung von Sanskrit-Schauspielen reflektiert. Die vorgestellte Herangehensweise ermöglichte auch die automatische Erstellung des als Anhang enthaltenen Index aller in dem Schauspiel vorkommenden Sanskrit- und Prakrit-Wortformen.
Purpose
The purpose of this study is to investigate changes over time in quality of life (QoL) in incurable lung cancer patients and the impact of determinants like molecular alterations (MA).
Methods
In a prospective, longitudinal, multicentric study, we assessed QoL, symptom burden, psychological distress, unmet needs, and prognostic understanding of patients diagnosed with incurable lung cancer at the time of the diagnosis (T0) and after 3 (T1), 6 (T2) and 12 months (T3) using validated questionnaires like FACT-L, National Comprehensive Cancer Network (NCCN) Distress Thermometer (DT), PHQ-4, SCNS-SF-34, and SEIQoL.
Results
Two hundred seventeen patients were enrolled, 22 (10%) with reported MA. QoL scores improved over time, with a significant trend for DT, PHQ-4, and SCNS-SF-34. Significant determinants for stable or improving scores over time were survival > 6 months, performance status at the time of diagnosis, and presence of MA. Patients with MA showed better QoL scores (FACT-L at T1 104.4 vs 86.3; at T2 107.5 vs 90.0; at T3 100.9 vs 92.8) and lower psychological distress (NCCN DT at T1 3.3 vs 5; at T2 2.7 vs 4.5; at T3 3.7 vs 4.5; PHQ-4 at T1 2.3 vs 4.1; at T2 1.7 vs 3.6; at T3 2.2 vs 3.6), but also a worsening of the scores at 1 year and a higher percentage of inaccurate prognostic understanding (27 vs 17%) compared to patients without MA.
Conclusion
Patients with tumors harboring MA are at risk of QoL deterioration during the course of the disease. Physicians should adapt their communication strategies in order to maintain or improve QoL.